Such risks
and uncertainties include, but are not limited to: our ability to achieve our financial, strategic
and operational plans or initiatives; our ability to predict
and manage medical costs
and price effectively
and develop
and maintain good relationships with physicians, hospitals
and other health care providers; the impact of modifications to our operations
and processes; our ability to identify potential strategic acquisitions or transactions
and realize the expected benefits of such transactions, including with respect to the Merger; the
substantial level of government regulation over our business
and the potential effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions
and / or guaranty fund assessments; uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness
and security of our information technology
and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer
time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts
and Cigna; unexpected costs regarding the proposed Merger; diversion of management's
attention from ongoing business operations
and opportunities during the pendency of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific risks
and uncertainties discussed in our most recent report on Form 10 - K
and subsequent reports on Forms 10 - Q
and 8 - K available on the Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K
and subsequent reports on Forms 10 - Q
and 8 - K available on the Investor Relations section of www.express-scripts.com.
However, it did influence an already contentious electoral campaign in Austria, consumed
substantial amounts of
time and attention,
and, forced the incumbent to spent
time defending himself
and his campaign, failing to distance himself from the underhanded tactics of his erstwhile campaign advisor Silberstein, while looking somewhat incompetent
and ignorant about what was going on.
John Cho, who drew my
attention for the first
time when he appeared in «Harold & Kumar Go to White Castle» (2004), shows another side of his talent here in this film,
and he has an unaffected onscreen chemistry with his co-star Haley Lu Richardson, who previously played a
substantial supporting character in «The Edge of Seventeen» (2016)
and will probably advance further considering her charming presence on the screen.